Related Experiment Video
Updated: Oct 1, 2025

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.2K
Ferroptosis: A New Strategy for Cancer Therapy
Yu Chen1, Zhihua Fan2, Shen Hu3
1Department of Pediatric Surgery, Guangdong Women and Children Hospital, Guangzhou, China.
Frontiers in Oncology
|March 7, 2022
Summary
Ferroptosis, a novel iron-dependent cell death, impacts cancer drug resistance. Understanding its roles in amino acid, iron, and lipid metabolism is key for future cancer therapies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Ferroptosis is a distinct form of regulated cell death characterized by iron dependency.
- Key features involve alterations in amino acid, iron, and lipid metabolism, alongside reactive oxygen species (ROS) production.
Purpose of the Study:
- To review the current research progress on ferroptosis in the context of tumors.
- To explore the relationship between ferroptosis and cancer development, progression, and drug resistance.
Main Methods:
- Literature review of studies investigating ferroptosis mechanisms.
- Analysis of research linking ferroptosis to various cancer types and therapeutic resistance.
Main Results:
- Ferroptosis is mechanistically distinct from other cell death modalities.
- Significant associations exist between ferroptosis dysregulation and cancer pathogenesis.
- Ferroptosis plays a crucial role in the development of drug resistance in various cancers.
Conclusions:
- Ferroptosis is an emerging area with significant implications for cancer treatment.
- Further research into ferroptosis mechanisms may offer new therapeutic strategies for overcoming drug resistance.
- This review provides a foundation for future investigations and clinical applications of ferroptosis in oncology.
More Related Videos
Related Concept Videos
Necrosis
4.9K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.9K
Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

